(redirected from Adrenergic agonist)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Related to Adrenergic agonist: Adrenergic antagonist
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for agonist

the principal character in a work of fiction


Related Words

someone involved in a contest or battle (as in an agon)

a muscle that contracts while another relaxes

Related Words

(biochemistry) a drug that can combine with a receptor on a cell to produce a physiological reaction

Related Words

References in periodicals archive ?
Given the risk of long-term neurophysiologic and behavioural impairment, the use of beta 2 adrenergic agonists should be limited to proven indications when alternate drugs are ineffective or unavailable and the risks of the untreated disease to the mother and fetus are greater than the risk of the beta 2 adrenergic agonist," said Dr Frank R.
The mechanism of action for salmeterol is a (LABA) long-acting beta 2 adrenergic agonist.
Local infusion of alpha-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys.
2] adrenergic agonist, produces an antinociceptive effect and improves analgesic efficacy when combined with local anaesthetic (4).
Phenylephrine is a sympathomimetic agent which acts primarily as an alpha adrenergic agonist.
2] adrenergic agonist that's been used for more than a decade in the United Kingdom.
The BESIDE results appear to indicate that adding mirabegron therapy, a Beta-3 adrenergic agonist, to solifenacin therapy, an antimuscarinic, may offer relief from the burden of OAB," said Professor Marcus Drake, MA, DM, FRCS (Urol), University of Bristol and Bristol Urological Institute, Bristol, UK.
An adrenergic agonist also may be a useful add-on medication to treat comorbid tics and residual impulsivity, hyperactivity, or aggression, Dr.
NYSE:AGN) For neuropathic pain, pre-clinical work studying ACADIA's alpha adrenergic agonist compound yielded encouraging data.
Other studies featuring OE to be presented at the NAASO meeting include: (Poster 437-P) "Additive Effects of Combined Treatment of Overweight Rats With OE, and Dexfenfluramine, Sibutramine or Phentermine"; and, (Poster 436-P) "Additive Effects of OE and Beta-3 Adrenergic Agonist on Rat Body Energy.
Brimonidine tartrate, the active ingredient in ALPHAGAN(R)/ALPHAGAN(R) P is a relatively selective alpha-2 adrenergic agonist for ophthalmic use.
Nonhormonal therapies include serotonin receptor inhibitors (venlafaxine and paroxetine) and alpha-2 adrenergic agonists (clonidine), which are most appropriate for the treatment of vasomotor symptoms.